Specifically, Tamoxifen upregulated SERPINA3 and IGLV7-43, while Anastrozole-treated T47Ds downregulated IGCL3 (Supplementary Table 2) which is indicated by the Human Protein Atlas as being associated with favourable outcome in breast cancer. This evidence concerns the gene SERPINA3 and breast carcinoma.